Non-interventional (observational) post-licensure study to assess the effectiveness and safety of recombinant zoster vaccine in adults aged =18 years with psoriasis or psoriatic arthritis (EPI-ZOSTER-045 VE US 216976)

20/10/2023
29/07/2026
EU PAS number:
EUPAS107230
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s), other

Kaiser Permanente Health Connect, United States

Data sources (types)

Administrative healthcare records (e.g., claims)
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No